Qingting Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Pulmonary Hypertension Research and Treatments
Papers in
-
- Circular RNAs in diseases 7
- PI3K/AKT/mTOR signaling in cancer 6
- Sphingolipid Metabolism and Signaling 3
- RNA modifications and cancer 3
-
- Pulmonary Hypertension Research and Treatments 17
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Co-authors
- Manxiang Li (43 shared papers)Xin Yan (26 shared papers)Wenhua Shi (28 shared papers)Limin Chai (31 shared papers)Qianqian Zhang (31 shared papers)Jian Wang (22 shared papers)Cui Zhai (19 shared papers)Shaojun Li (15 shared papers)
- Journals
- European Journal of Pharmacology (4 papers)Life Sciences (4 papers)Journal of Cancer (3 papers)Scientific Reports (2 papers)Respiratory Research (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Qingting Wang
49 papers receiving 794 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 139
- Pulmonary and Respiratory Medicine 293
- Molecular Biology 383
- Microbiology 4
- Immunology 98
Countries citing papers authored by Qingting Wang
This map shows the geographic impact of Qingting Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingting Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingting Wang more than expected).
Fields of papers citing papers by Qingting Wang
This network shows the impact of papers produced by Qingting Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingting Wang. The network helps show where Qingting Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingting Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 95 | |
| 2 | 2021 | 94 | |
| 3 | 2018 | 58 | |
| 4 | 2018 | 42 | |
| 5 | 2018 | 42 | |
| 6 | 2018 | 33 | |
| 7 | 2018 | 26 | |
| 8 | 2021 | 25 | |
| 9 | 2018 | 24 | |
| 10 | 2018 | 23 | |
| 11 | 2019 | 22 | |
| 12 | 2021 | 22 | |
| 13 | 2022 | 21 | |
| 14 | 2017 | 20 | |
| 15 | 2019 | 20 | |
| 16 | 2019 | 16 | |
| 17 | 2017 | 16 | |
| 18 | 2019 | 14 | |
| 19 | 2017 | 13 | |
| 20 | 2022 | 12 |
About Qingting Wang
Qingting Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Immunology, having authored 50 papers that have together received 803 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (17 papers), Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Protease and Inhibitor Mechanisms (4 papers), Sphingolipid Metabolism and Signaling (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (139 citations), Pulmonary and Respiratory Medicine (293 citations), Molecular Biology (383 citations), Microbiology (4 citations) and Immunology (98 citations). Qingting Wang has collaborated with scholars based in China, United States and France. Frequent co-authors include Manxiang Li, Xin Yan, Wenhua Shi, Limin Chai, Qianqian Zhang, Jian Wang, Cui Zhai, Shaojun Li, Xinming Xie and Wei Feng. Their work appears in journals such as European Journal of Pharmacology, Life Sciences, Journal of Cancer, Scientific Reports and Respiratory Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.